Block Drug Sales Up 3.4% To $822.4 Mil. In FY 1999, Fueled By Acquisitions
This article was originally published in The Tan Sheet
Executive Summary
Block Drug sales for the year ended March 31 climbed 3.4% to $822.4 mil., bolstered by "important acquisitions and new product introductions," the company said June 8. The sales figure excludes the effects of the divestiture of three household products in the fiscal first quarter and the strong U.S. dollar, Block noted. After accounting for those effects, net sales actually declined 4.9% to $821.1 mil.